Enterprise Value
2.152M
Cash
2.557M
Avg Qtr Burn
-2.394M
Short % of Float
3.24%
Insider Ownership
0.42%
Institutional Own.
3.71%
Qtr Updated
12/31/23
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Twirla (levonorgestrel and ethinyl estradiol) transdermal system Details Contraceptive, Progestin and estrogen contraception | Approved Quarterly sales | |
AG890 Details Contraceptive, Progestin-only contraception | Phase 2 Update |